Finland awaits EMA position as official links AstraZeneca vaccine to blood clots
Apr 06 2021
National Vaccination Committee President Maria Theodoridou advised calm ahead of the European Medicines Agency's upcoming assessment on whether the AstraZeneca vaccine is associated with the development of thrombosis and thrombocytopenia.
As per reports, Cavaleri told Il Messaggero "In my opinion, we can say it now, it is clear there is a link with the vaccine". What causes this reaction, however, we still do not know.
Cavaleri added that the EMA would say there is a link although the regulator would not likely be in a position this week to give an indication regarding the age of individuals to whom the AstraZeneca shot should be given.
Use of the AstraZeneca vaccine was temporarily halted in many countries in March after several cases of blood clots were found in Norway.
A number of countries have imposed restrictions on the use of the AstraZeneca vaccine, especially in younger adults.
"In my opinion, we can say it now, it is clear there is a link with the- vaccine".
So far in Ireland, over 203,000 doses of the AstraZeneca vaccine have now been administered.
"We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine", he said.
An investigation is also underway in the United Kingdom, where researchers are looking at the possibility of links between the AstraZeneca vaccine and rare blood clots.
At the time, the EMA had pointed out that it would be carrying out more reviews of the vaccine's effects as time went on, and this latest update goes to show it's sticking to its word.
In total, the United Kingdom has ordered 457 million doses, of which 100 million are from AstraZeneca.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that of those 30 people, seven had died as of 24 March.
Experts from the European Medicines Agency are meeting today to finalise their evaluation of rare cases of blood clotting and its possible relationship with AstraZeneca's Covid-19 vaccine, whose use is suspended in some European countries for people under 60 years of age.
In Germany, there have been 31 suspected cases of CVST - 19 accompanied by a drop in blood platelets - with nine deaths, according to the Paul-Ehrlich Institute.